fig1
From: Connecting academia and industry for innovative drug repurposing in rare diseases: it is worth a try
Figure 1. mTOR signal transduction pathway[15]. mTOR: Mammalian target of rapamycin; PIK3CA: phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; AKT: protein kinase B.
